• No results found

17-hydroxyprogesterone

17 Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double blind, randomized clinical trial

17 Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double blind, randomized clinical trial

... of 17-hydroxyprogesterone caproate (17P) given to women with preterm rupture of the membranes (PROM) will prolong pregnancy and thereby reduce neonatal ...

9

Screening for Congenital Adrenal Hyperplasia: The Delfia Screening Test Overestimates Serum 17-Hydroxyprogesterone in Preterm Infants

Screening for Congenital Adrenal Hyperplasia: The Delfia Screening Test Overestimates Serum 17-Hydroxyprogesterone in Preterm Infants

... Overestimates Serum 17-Hydroxyprogesterone in Preterm Infants Screening for Congenital Adrenal Hyperplasia: The Delfia Screening Test. Services[r] ...

5

Plasma Progesterone and 17 hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia

Plasma Progesterone and 17 hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia

... Plasma 17-hydroxyprogesterone (17-OHP) concentrations in normal men averaged ...the 17-OHP originated from the Leydig cell. The 17-OHP production rate was ...Plasma 17-OHP has a ...

11

Plasma 17 hydroxyprogesterone/cortisol ratio is not a predictor of systemic hypotension in extremely premature infants

Plasma 17 hydroxyprogesterone/cortisol ratio is not a predictor of systemic hypotension in extremely premature infants

... the 17-hy- droxyprogesterone (17-OHP)/cortisol ratio as a marker of immature11-beta hydroxylase activity can predict severe systemic hypotension in preterm neo- ...and 17-OHP concen- trations were ...

7

Neonatal Screening for Congenital Adrenal Hyperplasia: 17-Hydroxyprogesterone Levels and CYP21 Genotypes in Preterm Infants

Neonatal Screening for Congenital Adrenal Hyperplasia: 17-Hydroxyprogesterone Levels and CYP21 Genotypes in Preterm Infants

... It is widely known that it is difficult to interpret the result of a CAH screening test when the patient is born preterm. The spread of 17-OHP values among preterm infants also was very large, especially for ...

10

Management of Congenital Adrenal Hyperplasia Using Serum Dehydroepiandrosterone Sulfate and 17-Hydroxyprogesterone Concentrations

Management of Congenital Adrenal Hyperplasia Using Serum Dehydroepiandrosterone Sulfate and 17-Hydroxyprogesterone Concentrations

... Of 34 evaluations, a definite assessment of adequacy of control could be arrived at 25 times using urinary values and 22 times using both serum DHEA-S and 17-OHP concentrations.. DHEA-S [r] ...

7

Intramuscular 17 hydroxyprogesterone caproate to prevent preterm birth among HIV infected women in Zambia: study protocol of the IPOP randomized trial

Intramuscular 17 hydroxyprogesterone caproate to prevent preterm birth among HIV infected women in Zambia: study protocol of the IPOP randomized trial

... Methods: The Improving Pregnancy Outcomes with Progesterone (IPOP) study is a Phase III double-masked, placebo-controlled, randomized trial of intramuscular 17-alpha hydroxprogesterone caproate (17P) to prevent ...

9

Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study

Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study

... 17-OHP: 17-hydroxyprogesterone; DHEAS: Dehydroepiandrosterone sulfate; DLQI: Dermatology life quality index; GAGS: Global acne grading system; MRKH: Mayer-Rokitansky-Küster-Hauser syndro[r] ...

8

The Effects of Gestational Age and Birth Weight on False-Positive Newborn-Screening Rates

The Effects of Gestational Age and Birth Weight on False-Positive Newborn-Screening Rates

... and 17- hydroxyprogesterone FPRs was so large relative to the other 16 analytes, that even if delaying specimen collec- tion were to have show no additional FPR reduction, our results show a def- inite ...

9

Problem Solving in Clinical Endocrinology

Problem Solving in Clinical Endocrinology

... PSEM-Prelims.qxd 10/18/06 4:40 PM Page vii Abbreviations 17-OHP 17-hydroxyprogesterone ACTH adrenocorticotrophic hormone ADH antidiuretic hormone AECA anti-endothelial cell antibodies AI[r] ...

12

In Vitro Hydroxylation of Steroids by Whole Adrenal Homogenates of Beef, Normal Man, and Patients with the Adrenogenital Syndrome

In Vitro Hydroxylation of Steroids by Whole Adrenal Homogenates of Beef, Normal Man, and Patients with the Adrenogenital Syndrome

... This study gives direct evidence of a deficiency of 21-hydroxylation: Two diseased adrenal glands were unable to convert 17-hydroxyprogesterone into either 11-desoxycortisol or cortisol;[r] ...

7

Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study

Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study

... of 17- hydroxyprogesterone (17-OHP) was initially deter- mined by enzyme linked immunosorbent assay (ELISA) (Siemens Medical Solutions Diagnostics, CA, ...of 17-OHP values were subjected to ...

8

Blood levels and production rate of 17 hydroxypregnenolone in man

Blood levels and production rate of 17 hydroxypregnenolone in man

... blood 17-hydroxypregnenolone to blood 17-hydroxyprogesterone and dehydroepiandrosterone was ...phase, 17-hydroxyprogesterone derived from blood 17-hydroxypregnenolone could be ...

10

The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial

The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial

... 17-OHP: 17-hydroxyprogesterone; A2: Androstedione; ACE: Angiotensin- converting enzyme; ANCOVA: Analysis of Covariance; AUC: Area under the curve; CONSORT: Consolidated Standards of Reporting Trials; ...

5

Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report

Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report

... nmol/L); 17-hydroxyprogesterone (17-OHP) was 1.44 ng/ml (0.05–1.02 ng/ml); and human anti-Müllerian hormone was 16.40 ng/ml (2.80–6.30 ng/ml). Karyotype analysis showed a karyotype of 46,XX. The ...

6

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth

... We searched MEDLINE for all publications between January 1966 and March 2013 for articles reporting on pro- gestin use in pregnancy. We used the following search terms: “progesterone”, “17-alpha ...

9

PubMedCentral-PMC5774863.pdf

PubMedCentral-PMC5774863.pdf

... distinguish between “preterm birth” and “miscarriage.” Studies suggest that women with a history of a prior preterm birth between 16 and 20 weeks of gestation have an increased risk of recurrent second trimester loss and ...

13

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth

... This risk mitigation resulted in high usability and acceptance of this device that represents a novel design for viscous drug delivery and which provides health care professionals wit[r] ...

12

Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety

Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety

... Weekly IM injections of 17 OHP-C may be undesirable to a portion of the population at risk for preterm delivery. Progesterone administered intramuscularly has been associated with several systemic and local skin ...

10

Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases

Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases

... and hydroxyprogesterone products were extracted from 5 mL volumes of cell-free culture super- natant with 3 × 2 mL volumes of ethyl acetate which were pooled and evaporated to dryness using a centrifu- gal ...

13

Show all 10000 documents...

Related subjects